Current role
Biotechnology · Healthcare
Board Member
2023-01-01–present
Katie Ellias
Board Member
SAB Biotherapeutics, Inc. (SABS)Equibles does not estimate personal net worth.
About Katie Ellias
Katie Ellias is recorded as Board Member at SAB Biotherapeutics, Inc. (SABS) since January 1, 2023. The newest filing on record that lists Katie Ellias as Board Member at SAB Biotherapeutics, Inc. (SABS) is dated April 30, 2026. SAB Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at SAB Biotherapeutics, Inc. includes Samuel J. Reich (CEO and Board Member), David Zaccardelli (Chairman and Board Member), Lucy To (CFO) and 7 others.
Affiliation history
-
Current
2023-01-01–present
Last confirmed April 30, 2026
Company network
Leadership on record at SAB Biotherapeutics, Inc.
- Samuel J. Reich CEO, Board Member
- David Zaccardelli Chairman, Board Member
- Lucy To CFO
- Mark Conley CFO
- Michael King CFO
- Christoph Bausch COO
- Andrew D. Moin Board Member
- Andrew Moin Board Member
- David Link Board Member
- Dr. Jay S. Skyler Board Member
Recent activity
No call appearances or filed executive changes recorded yet.